Patents by Inventor John W. Angers

John W. Angers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5379578
    Abstract: A cane harvester including sugar cane lifting, gathering and severing structure operative to engage, lift and sever the tops and bottoms of cane oriented in a row along which the harvester is advanced with the cut cane subsequently being conveyed in an upright position and then discharged rearwardly and downwardly, in a rearwardly and upwardly inclined position, into a forwardly and upwardly opening cutter assembly operative to simultaneously sever the cane into billet lengths at points spaced predetermined distances therealong with leaf portions of the cane being simultaneously severed at the same points spaced along the cane to thereby provide cleanly cut cane billets having had a majority of the leaf portions severed therefrom and thus substantially ready for processing in the manufacture of cane sugar.
    Type: Grant
    Filed: January 25, 1994
    Date of Patent: January 10, 1995
    Assignee: Agronomics, Inc.
    Inventors: Walter J. Landry, John W. Angers
  • Patent number: 4618494
    Abstract: Type 1 Diabetes and other virus-induced or autoimmunological diseases are treated with Human Immune Factors. These Human Immune Factors are extracted from blood cells by activating said blood cells with human lymphoblastoid interferon-alpha or staphage lysate or other activator or combination of activators. Human Immune Factors are purified and made suitable for pharmaceutical use by isolating compounds with molecular weights between about 1,000 and about 25,000 daltons.
    Type: Grant
    Filed: July 20, 1984
    Date of Patent: October 21, 1986
    Assignee: Immunology Development Corporation
    Inventor: John W. Angers
  • Patent number: 4311686
    Abstract: New and improved methodology for the diagnosis of a disease from blood sample analysis is disclosed and comprises: the preparation of a putative antigenic body substance extract, which is specific to disease-sensitized blood leukocytes, from the pooled, like body substances of a plurality of donors known to have the disease of interest; the mixture of said extract with the blood sample leukocytes; the promotion of the reaction therebetween to modify a characteristic of the disease-sensitized leukocytes, if any, of the blood sample; and the determination of the extent, if any, to which said characteristic has been modified. In multiple sclerosis diagnosis, said body substance may be blood or urine; while for malignant disease (for example breast cancer, or cancer of the head and neck) said body substance may be blood, urine, pleural fluid, ascites fluid, supernates of tumor cells or tumor cells grown in culture media.
    Type: Grant
    Filed: April 30, 1979
    Date of Patent: January 19, 1982
    Assignee: The Immunology Development Corporation
    Inventors: John W. Angers, Lazar Korik